In order to strengthen supervision of the pharmaceutical market and curb illegal purchases and sales, the Jiangsu Provincial Food and Drug Administration recently took effective measures to further strengthen the management of ephedrine-containing compound preparations.
First, it is strictly forbidden that relevant companies sell ephedrine compound preparations to wholesale companies that have not obtained the qualifications for the operation of protein assimilation and peptide hormones.
The second is to urge all localities to urge relevant drug production and wholesale enterprises to establish a strict sales management system, and report sales flow of ephedrine compound preparations on a quarterly basis in order to prevent illegal events such as fraudulent purchase or hedging.
The third is to increase the daily supervision of the existing 17 ephedrine compound preparation enterprises and 223 operating enterprises in the province, and organize the centralized inspection of abnormal flow conditions.
At present, there has been no inflow of illegal channels into the production of drugs in Jiangsu Province.
First, it is strictly forbidden that relevant companies sell ephedrine compound preparations to wholesale companies that have not obtained the qualifications for the operation of protein assimilation and peptide hormones.
The second is to urge all localities to urge relevant drug production and wholesale enterprises to establish a strict sales management system, and report sales flow of ephedrine compound preparations on a quarterly basis in order to prevent illegal events such as fraudulent purchase or hedging.
The third is to increase the daily supervision of the existing 17 ephedrine compound preparation enterprises and 223 operating enterprises in the province, and organize the centralized inspection of abnormal flow conditions.
At present, there has been no inflow of illegal channels into the production of drugs in Jiangsu Province.